verapamil has been researched along with Island Cell Tumor in 5 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Excerpt | Relevance | Reference |
---|---|---|
"The efficacy of treatment with either verapamil (V), the long-acting somatostatin analogue octreotide (OCT) alone, and the combined treatment (V + OCT) were studied in a patient with a symptomatic metastasized malignant insulinoma." | 7.67 | Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug? ( Fischer, HR; Hackeng, WH; Lems, WF; Stehouwer, CD, 1989) |
"The efficacy of treatment with either verapamil (V), the long-acting somatostatin analogue octreotide (OCT) alone, and the combined treatment (V + OCT) were studied in a patient with a symptomatic metastasized malignant insulinoma." | 3.67 | Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug? ( Fischer, HR; Hackeng, WH; Lems, WF; Stehouwer, CD, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Marinis, L | 1 |
Barbarino, A | 1 |
Shapiro, S | 1 |
Kaneko, Y | 1 |
Baum, SG | 1 |
Fleischer, N | 1 |
Harty, RF | 1 |
Jain, DK | 1 |
McGuigan, JE | 1 |
Stehouwer, CD | 1 |
Lems, WF | 1 |
Fischer, HR | 1 |
Hackeng, WH | 1 |
Imanaka, S | 1 |
Matsuda, S | 1 |
Ito, K | 1 |
Matsuoka, T | 1 |
Okada, Y | 1 |
5 other studies available for verapamil and Island Cell Tumor
Article | Year |
---|---|
Calcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor.
Topics: Adenoma, Islet Cell; Adolescent; Adult; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Gly | 1980 |
The role of calcium in insulin release from hamster insulinoma cells.
Topics: Adenoma, Islet Cell; Animals; Calcium; Cricetinae; Cyclic AMP; Deoxyglucose; Female; Glucagon; Gluco | 1977 |
Mechanisms of vasoactive intestinal peptide release in short-term culture of vasoactive intestinal peptide-producing tumor.
Topics: 1-Methyl-3-isobutylxanthine; Adenoma, Islet Cell; Calcimycin; Calcium; Cells, Cultured; Cyclic AMP; | 1988 |
Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
Topics: Adenoma, Islet Cell; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Insulinom | 1989 |
Medical treatment for inoperable insulinoma: clinical usefulness of diphenylhydantoin and diltiazem.
Topics: Adenoma, Islet Cell; Aged; Benzazepines; Blood Glucose; C-Peptide; Celiac Artery; Diltiazem; Female; | 1986 |